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Abstract: The synthesis, base-pairing properties and in vitro
and in vivo characteristics of 5-methyl-isocytosine (isoCMe)
and isoguanine (isoG) nucleosides, incorporated in an
HNA(h) (hexitol nucleic acid)–DNA(d) mosaic backbone, are
described. The required h-isoG phosphoramidite was pre-
pared by a selective deamination as a key step. As demon-
strated by Tm measurements the hexitol sugar showed
slightly better mismatch discrimination against dT. The d-
isoG base mispairing follows the order T>G>C while the h-
isoG base mispairing follows the order G>C>T. The h- and
d-isoCMe bases mainly mispair with G. Enzymatic incorpora-
tion experiments show that the hexitol backbone has a varia-
ble effect on selectivity. In the enzymatic assays, isoG misin-
corporates mainly with T, and isoCMe misincorporates mainly
with A. Further analysis in vivo confirmed the patterns of
base-pair interpretation for the deoxyribose and hexitol
isoCMe/isoG bases in a cellular context, through incorporation
of the bases into plasmidic DNA. Results in vivo demonstrat-
ed that mispairing and misincorporation was dependent on
the backbone scaffold of the base, which indicates rational
advances towards orthogonality.
Introduction
Encoding heritable information in polymers other than DNA
and RNA in vivo will result in the creation of XNA (Xeno nucleic
acid) modified organisms (XMO’s) unable to communicate this
information with the environment.[1] Several artificial nucleic
acids have been considered as XNA,[2] and few of them have
been evaluated in vivo.[3] Transliteration of XNA to DNA in vivo
has been described for base-modified XNA,[3b] for sugar-modi-
fied XNA[3a,c] and for XNA’s in which both sugar and base are
modified.[3c,d] The substitution of the thymine base by chlorour-
acil in a bacterial genome[4] demonstrates the feasibility of sup-
porting life with a genome consisting of a non-natural base.
A recent breakthrough in the field of XNA has been reported
by Malyshev et al. ,[3e] which shows recognition of a synthetic
base pair in vivo, and by Pinheiro et al. ,[5] which shows that up
to six artificial polymers can be used to propagate genetic in-
formation in vitro. Whatever the design may be, an ideal or-
thogonal genomic XNA should preferentially contain a modified
backbone as well as modified base pairs.
The development of an alternative (third) base pair has been
primarily pursued for the expansion of the genetic alphabet of
DNA. The isoguanine[6] (isoG):isocytosine[7] (isoC) nonstandard
base pair (Figure 1) was first proposed by A. Rich,[8] and it
forms three H-bonds similar to the guanine (G):cytosine (C)
base pair. Due to the low stability of isoC under alkaline condi-
tions, the 5-methyl derivative (isoCMe) was used instead.[9] This
unnatural isoG:isoCMe base pair was studied by S. Benner,[10]
and evaluated in PCR amplification showing 96% fidelity.[11] Re-
sults from these studies revealed that the pairing selectivity in
DNA was not adequate and restricted its applications. During
studies on the incorporation of isoG opposite to isoCMe in DNA
by polymerase misincorporation of thymidine (T) and/or uri-
dine (U) opposite to the minor enol tautomer[12] of isoG was
observed. Progress was achieved using 7-deaza-isoG,[13] halo-
genated 7-deaza-isoG,[14] and 8-aza-isoG[15] as analogues of
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isoG, showing a shift towards the keto form in the tautomeric
keto–enol equilibrium. However, the error rate per cycle for
the amplification of isoCMe :isoG systems was still too high,
which may result in unidirectional loss of information during
amplification[16] (i.e. revert to an all-natural genetic system).
Changing the chemistry of the nucleic acid backbone may
have an influence on base pairing. In addition, studies regard-
ing enzymatic incorporation of sugar-modified isoCMe and isoG
have not been reported. Hexitol nucleic acid (HNA)[17] is one
example of a modified backbone that can be used to study
how sugar modification influences duplex stability, the encod-
ing of information, and its passage through heredity.[3a,c] HNA
has an additional methylene group between C1’ and O4’ of
the b-d-2-deoxyribose moiety and forms a very stable self-
complementary duplex and stable duplexes with their natural
counterparts DNA and RNA.[17a] The order of duplex stability is:
HNA–HNA>HNA–RNA>HNA–DNA.[17a] HNA forms A-type du-
plexes. An HNA-dependent DNA polymerase and a DNA-de-
pendent HNA polymerase are available for biological applica-
tions.[5] Here, as part of our continuing research on the selec-
tion of base- and sugar-modified nucleic acids as orthogonal
information systems,[3c,d, 18] we investigated the isoG:isoCMe
base-pairing system in an HNA context. Therefore, the com-
pounds depicted in Figure 2 were synthesised and investigated
for their base-pairing properties. The compounds were ana-
lysed experimentally, utilising in vitro hybridization and DNA
polymerase incorporation assays as well as an in vivo HNA-de-
pendent DNA synthesis assay.
Results and Discussion
The phosphoramidite building
blocks of d-isoG 6 was synthes-
ised from 5 by following a re-
ported procedure (Scheme 1).[19]
As depicted in Scheme 2, the
synthesis of h-isoG started from
the 2-O-tosylate of 1,5-anhydro-
4,6-O-benzylidene-d-glucitol (7), which was prepared as previ-
ously reported by us.[20] The tosylated sugar 7 was treated with
the sodium salt of 2-aminoadenine in DMF at 90 8C for 12 h
yielding 79% of 2,6-diaminopurine hexitol nucleoside 8. HMBC
of 2D NMR was used to illustrate the correct connection of the
nucleobase to the sugar moiety. For compound 8, the HMBC
spectrum showed that the proton of C-3’ of the sugar moiety
was coupled with the C-4 and C-8 of the 2-aminoadenine
moiety, thus confirming that the C-3’ of the sugar moiety is
linked to the N-9 of the adenine moiety via a C¢N bond. More-
over, the spectral and analytical data of 8 were found to be in
agreement with a previous report.[21] The cleavage of the ben-
zylidene–acetal protecting group was carried out using acetic
acid and water at 60 8C for 4 h, to obtain compound 9 in 91%
yield.
In the next step, the 2-aminoadenosine hexitol 9 was deami-
nated selectively by diazotisation of the 2-NH2 group using
sodium nitrate in acetic acid and water at 55 8C for 10 min, af-
fording h-isoG 2 in 76% yield. The free amino group of com-
pound 2 was protected with an N,N-dimethylamino methyli-
dene residue by using dimethylformamide dimethyl acetal in
methanol at room temperature for 12 h. As has been described
for the isoguanosine derivatives, the protection of the 2-oxo
group with a diphenylcarbamoyl residue resulted in significant-
ly higher coupling yields during oligonucleotide synthesis.[22]
Hence, 10 was treated with diphenylcarbamoyl chloride in pyr-
idine at room temperature for one hour to furnish the 2-oxo-
protected nucleoside 11 in 76% yield. Subsequently, com-
pound 11 was tritylated using dimethoxytrityl chloride
(DMTrCl) in pyridine with 4-dimethylaminopyridine (DMAP) as
a catalyst. Phosphitylation of the DMTr derivative 12 was per-
formed in anhydrous dichloromethane in the presence of 1H-
tetrazole and 2-cyanoethyl N,N,N’,N’-tetraisopropylphosphoro-
diamidite, furnishing the phosphoramidite 13.
Figure 1. Putative base-pair motifs of duplexes with antiparallel strand orientation.
Figure 2. Deoxyribose and hexitol isoG and isoCMe nucleosides.
Scheme 1. Synthesis of phosphoramidite of protected deoxyribose-isoG.
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The phosphoramidite of d-isoCMe 15 was accessed by follow-
ing a procedure reported by Seela[23] (Scheme 3), starting from
thymidine 14. For the synthesis of the h-isoCMe 25, the re-
quired 1’,5’-anhydro-4’,6’-O-benzylidene-3’-O-methanesulfonyl-
2’-deoxy-2’-(5-methyl-isocytosin-1-yl)-d-altro-hexitol (17) was
prepared from commercially available 1,5:2,3-dianhydro-4,6-O-
benzylidene-d-allitol (16) by using an existing procedure.[24]
Compound 17 was treated with saturated ammonia (metha-
nol) in a sealed tube at 160 8C for 60 h affording the benzyli-
dene-protected h-isoCMe 19 in 70% yield. This one-pot two-
step reaction implies the in situ generation of a 2,3’-anhydro
nucleoside 18 that concomitantly undergoes nucleophilic
opening with ammonia at the C2 of the pyrimidinone ring
skeleton with an inversion of configuration at the C3’-position.
The protection of the C2 amino group of compound 19 was
carried out using dimethylformamide dimethyl acetal in meth-
anol at 65 8C for 3 h affording compound 20 in 80% yield. For
the deoxygenation of the C3’-hydroxy group, the Barton–
McCombie reaction was used. We first converted the hexitol
nucleoside 20 into the corresponding thiocarbamate 21 (88%
yield), which, after radical reduction in the presence of tributyl-
stannane and azobisisobutyronitrile (AIBN), gave the desired N-
protected isoCMe nucleoside 22 in 69% yield.
Removal of benzylidene acetal protective group led to com-
pound 23 in 93% yield. Subsequently, compound 23 was trity-
lated to 24 and finally phosphitylation was performed to
obtain the phosphoramidite 25 (Scheme 5).
Triphosphate synthesis
The triphosphate building blocks of deoxyribose-isoG (d-
isoGTP) and deoxyribose-isoCMe (d-isoCMeTP) were synthesised
following a reported protocol.[25] For the synthesis of triphos-
phate hexitol-isoG (h-isoGTP), the protected h-isoG 11 was
converted to h-isoGTP 26 in a one-pot reaction by the Ludwig
method.[26] In this procedure, regioselective phosphorylation of
the 6’-hydroxy group of the sugar moiety was carried out with
phosphoryl oxychloride in trimethyl phosphate followed by
the addition of tetrabutylammonium pyrophosphate. The reac-
Scheme 2. Synthesis of phosphoramidite of protected hexitol-isoG. a) 2,6-Diaminopurine, NaH, DMF, 90 8C, 12 h, 79%; b) CH3COOH/H2O 6:4, 60 8C, 4 h, 91%;
c) NaNO2, CH3COOH, H2O, 55 8C, 10 min, 76%; d) Me2NCH(OMe)2, CH3OH, RT, 12 h, 80%; e) Ph2NCOCl, iPr2NEt, pyridine, RT, 1 h, 76%, f) (MeO)2TrCl, pyridine,
0 8C to RT, 12 h, 73%, g) (iPr2N)2POC2H4CN, 1H-tetrazole, DCM, 0 8C to RT, 1 h, 75%.
Scheme 3. Synthesis of phosphoramidite of protected deoxyribose-isoCMe.
Scheme 4. Synthesis of the triphosphates 26 and 28. a) i) TMP, POCl3, 0 8C,
5 h; ii) Bu3N, (NBu4)3HP2O5, 30 min; iii) 25% NH3, 2 h; b) i) Ac2O, N,N-diisopro-
pylethylamine, DMAP, THF, RT, 20 min; ii) dichloroacetic acid, dichlorome-
thane, 0 8C to RT, 30 min; c) i) salicyl phosphorochloridite, pyridine/dioxane,
1 min, ii) (NBu3)2H2P2O7, NBu3, DMF, 30 min; iii) iodine, pyridine/water, 10 min;
iv) 25 % NH3, 2 h.
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tion product was deprotected with aqueous ammonia, isolated
by ion-exchange chromatography and finally purified by RP-
HPLC. As depicted in Scheme 4, the synthesis of h-isoCMeTP 28
started from DMTr-protected 24, which was further converted
to its 4’-acetate and removal of DMTr protecting group afford-
ed compound 27 in 59% over two steps. Compound 27 was
converted to h-isoCMeTP 28 by phosphorylation with salicyl
phosphorochloridite followed by addition of tributylammoni-
um pyrophosphate and final oxidation of intermediate with
iodine.[27]
The reaction product was deprotected with aqueous ammo-
nia and purified by ion-exchange chromatography and RP-
HPLC.
The oligonucleotides were prepared by using the common
phosphoramidite method on a solid support employing a DNA
synthesiser. The base-pairing properties of d-isoCMe and h-
isoCMe with d-isoG and h-isoG were examined by hybridising
oligomers with their complementary strands and determining
the Tm of the hybrids by temperature-dependent UV spectros-
copy. To investigate the base-pairing properties, the d-isoG nu-
cleoside 1 and the h-isoG nucleoside 2 were incorporated in
the antiparallel duplex 5’-(GGT AGC AG*C GGT G) replacing dG
residues by 1 and 2. The d-isoCMe 3 and h-isoCMe 4 nucleosides
were incorporated in the sequence 3’-(CCA TCG TC*G CCA C)
replacing dC residues by 3 and 4. The strength of hybridization
was studied by thermal denaturation experiments, which were
determined at 260 nm in NaCl (0.1m) buffer with KH2PO4
(20 mm, pH 7.5) and EDTA (0.1 mm) at a concentration of 4 mm
for each strand. Hexitol nucleosides (h-isoG 2 and h-isoCMe 4)
were incorporated opposite a deoxyribo-nucleoside (d-isoCMe 3
and d-isoG 1). Likewise, h-isoG:h-isoCMe was evaluated as base
pair. The stability of the duplexes was compared to the stabili-
ty of the natural DNA duplex containing C:G (Table 1, entry 1)
and isoCMe :isoG (entry 2) base pairs.
The d-isoCMe :d-isoG pair gives a somewhat more stable
duplex than the C:G pair, which may be due to the presence
of a 5-methyl group on the isoC nucleoside. Incorporation of
an h-isoG versus a d-isoCMe nucleoside (Table 1, entry 4) gives
Scheme 5. Synthesis of phosphoramidite of protected hexitol-isoCMe. a) sat. NH3 in CH3OH, 160 8C, 60 h, 70%; b) Me2NCH(OMe)2, CH3OH, 65 8C, 3 h, 88%;
c) Im2S, DMF, 12 h, 88%; d) AIBN, nBu3SnH, toluene, 80 8C, 3 h, 69%; e) CH3COOH/H2O (6:4), 60 8C, 4 h, 93%; f) (MeO)2TrCl, pyridine, 0 8C to RT, 12 h, 88%;
g) (iPr2N)2POC2H4CN, 1H-tetrazole, dichloromethane, 0 8C to RT, 1 h, 81%.
Table 1. Tm values of non-self-complementary antiparallel-stranded oligo-
nucleotide duplexes containing 1 (d-isoG) and 2 (h-isoG) hybridised
against 3 (d-isoCMe) and 4 (h-isoCMe).
Entry Duplex Tm [8C]
1 5’-GGT AGC AGC GGT G-3’
3’-CCA TCG TCG CCA C-5’
61.3
2 5’-GGT AGC A1C GGT G-3’
3’-CCA TCG T3G CCA C-5’
63.6
3 5’-GGT AGC A1C GGT G-3’
3’-CCA TCG T4G CCA C-5’
62.1
4 5’-GGT AGC A2C GGT G-3’
3’-CCA TCG T3G CCA C-5’
60.2
5 5’-GGT AGC A2C GGT G-3’
3’-CCA TCG T4G CCA C-5’
60.0
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a larger decrease in Tm (¢3.4 8C) than incorporation of an h-
isoCMe versus a d-isoG nucleoside (entry 3) (¢1.5 8C). The Tm
further decreases (¢3.6 8C) when both strands contain an hexi-
tol nucleoside (entry 5), which could be due to the fact that
only one single hexitol base pair is introduced into a full DNA
duplex.[17b] The experiment demonstrates that a stable iso-
CMe :isoG base pair can be formed within the context of
a DNA–HNA mosaic duplex. To investigate the selectivity of
base pairing of h-isoG and h-isoCMe, the four canonical nucleo-
sides (dA, dT, dC, and dG) were placed opposite to the modifi-
cation site, and Tm values were measured (Table 2). This study
is done towards the function of the potential use of h-isoG
and h-isoCMe in vivo. We wondered what the influence would
be on duplex stability when a natural nucleoside is incorporat-
ed opposite a hexitol nucleoside with an isoG or isoCMe base.
The base-pair stability for h-isoG decreases in the order d-
isoCMeh-isoCMe>GC>T>A, whereas for d-isoG it is d-
isoCMe>h-isoCMe>T>G>C@A. This means that d-isoG forms
the most stable mismatch with T and then with G, whereas h-
isoG forms the most stable mismatch with G and C and then
with T. The mismatch discrimination (DTm) is the lowest for h-
isoG and the highest for the isoCMe nucleosides. As with d-
isoCMe, h-isoCMe forms more stable mismatches with G than
with the other natural bases. An interesting observation is that
the h-isoG:h-isoCMe base pair is 8.8 8C more stable than the h-
isoG:dT base pair, whereas the d-isoG:d-isoCMe base pair is
7.8 8C more stable than the d-isoG:dT base pair.
Incorporation experiments
We investigated the role of a hexitol scaffold in affecting the
recognition and the selectivity of isoCMe :isoG base pairing
during polymerase-catalysed oligonucleotide synthesis. To de-
velop a successful orthogonal genetic system, mutual recogni-
tion of each base within a pair is imperative. Thus, eight
primed (P1) templates (T2, T3, T5, T6, T8, T9, T11 and T12)
were used (Table 3) and we tested the incorporation[28] of isoG
triphosphates opposite isoCMe nucleotides in the template and
its reverse.
Initially, we screened a series of mesophilic and thermosta-
ble polymerases for the incorporation of d-isoGMP (using d-
isoGTP as reagent) and h-isoGMP (using h-isoGTP as reagent)
opposite d-isoCMe and h-isoCMe nucleotides, respectively, in the
template. Several of the polymerases tested that is, Taq, Tfi
(exo-), T7 sequenase and Pol III a-subunit DNA polymerases
failed to recognise the base-pairing of isoG:isoCMe using the
hexitol sugar moiety (data not shown). However, Pfu (exo-),
Vent (exo-), Klenow fragment (KF) (exo-) and T4 (exo-) poly-
merases accepted both deoxyribose and hexitol isoGTP oppo-
site their respective counterparts, albeit with differing degrees.
For example, better incorporation was seen with Pfu (exo-),
Vent (exo-) and T4 (exo-) when a hexitol scaffold (vs. deoxyri-
bose) was used and the reverse was true for KF (exo-). Single
incorporation studies and extension experiments (incorpora-
tion of isoGMP opposite 3 consecutive isoC nucleotides) are
shown in Figures 3 and 4, respectively. Due to the similarity in
the results, only incorporation studies with Pfu (exo-) and KF
(exo-) are presented. With the hexitol scaffold, incorporation
was limited to only two nucleotides, with the exception of T4
(exo-) DNA polymerase that could only incorporate one nucleo-
tide. On the other hand, with the deoxyribose scaffold, an ex-
tension by three nucleotides was observed.
We also sought to test two evolved DNA polymerases origi-
nating from the archaeon Thermococus gorgonarius DNA poly-
merase. They were developed by the selection strategy called
compartmentalised self-replication and are capable of proces-
sive DNA to HNA synthesis (Pol6G12 mutant) and HNA to DNA
Table 2. Tm Values of non-self-complementary antiparallel-stranded oligo-
nucleotide duplexes containing 1, 2, [5’-GGT AGC A (1 or 2) C GGT G-3’] ;
3 and 4 [3’-CCA TCG T (3 or 4) G CCA C-5’] hybridised against comple-
mentary oligonucleotides of dA, dT, dC and dG.
A T C G DTm
d-isoG (1) 46.3 55.8 52.9 54.8 9.5
h-isoG (2) 48.3 51.2 53.4 53.7 5.4
d-isoCMe(3) 51.9 43.9 48.4 56.8 12.9
h-isoCMe(4) 47.7 41.1 46.1 54.8 13.7
Table 3. Sequence of the primer and templates used in the DNA poly-
merase incorporation experiments.
Sequence (5’ 3’)
P1 CAG GAA ACA GCT ATG AC
Sequence (5’ 3’)
T1 GTC CTT T GTC GAT ACT GCT AAA
T4 GTC CTT T GTC GAT ACT G CCC TAAA
T7 GTC CTT T GTC GAT ACT G GCT GAA
T10 GTC CTT T GTC GAT ACT G GGG CTG AA
T2, T3, T8, T9 GTC CTT T GTC GAT ACT G X* GT CAA
(X*=d-isoCMe, h-isoCMe, d-isoG, h-isoG for T2, T3, T8, T9, respectively)
T5, T6, T11, T12 GTC CTT T GTC GAT ACT G X*X*X* GT CAA
(X*=d-isoCMe, h-isoCMe, d-isoG, h-isoG for T5, T6, T11, T12, respectively)
Figure 3. Phosphorimage of the enzymatic incorporation of 100 mm of 2) d-
isoGTP into hybrid P1:T2 (1 d-isoCMe) and 3) h-isoGTP into hybrid P1:T3 (1 h-
isoCMe) using 0.08 UmL¢1 of Pfu (exo-) and KF (exo-). 0.08 UmL¢1 of thermosta-
ble inorganic pyrophosphatase (TIPP) was included. 1 represents the incor-
poration of 10 mm dGTP into hybrid P1:T1 (dC) (positive control). Reaction
time is 60 min.
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synthesis (RT521L mutant).[5] Utilising a hexitol scaffold, exten-
sion is only possible by two nucleotides. Accordingly we
wanted to see whether these evolved DNA polymerases are ca-
pable of HNA to HNA synthesis of more than two nucleotides;
however, incorporation of a third h-isoCMeMP (using h-isoCMeTP
as a reagent) opposite an h-isoG nucleotide was not observed
(data not shown).
We then tested the four polymerases for the incorporation
of d-isoCMeMP and h-isoCMeMP opposite d-isoG and h-isoG nu-
cleotides, respectively, in the template. Single incorporation
studies, using hybrid P1:T8, showed complete primer elonga-
tion by one and two nucleotides (incorporation of d-isoCMeMP
opposite d-isoG and a misincorporation opposite dG). On the
other hand, with hybrid P1:T9, full primer extension by only
a single nucleotide, except for KF (exo-) that could only extend
50% of the primer, was observed. With the extension experi-
ments (using hybrids P1:T12 and P1:T11), similar results to the
previous experiments were obtained. Two and three nucleo-
tides were incorporated with hexitol and deoxyribose, respec-
tively, as the sugar moiety. T4 (exo-) polymerase, however,
maintained the single nucleotide incorporation with the hexi-
tol scaffold.
It has been extensively reported that the reduced selectivity,
when using isoG in a isoCMe :isoG base-pairing system, arises
from mispairing with T. The major cause of this is stipulated to
be the tautomeric property of isoG.[14,29] However, formation of
a two-hydrogen bonded reverse wobble isoG:T base pair
could be another causative factor.[30] To test the effect of hexi-
tol scaffold in influencing selectivity, two primed (P1) templates
(T8 and T9) were used to investigate the incorporation of
dTMP (using dTTP as reagent) versus d-isoCMeMP (using d-iso-
CMeTP as reagent) against both d-isoG and h-isoG in the tem-
plate. The results showed that altering the sugar moiety influ-
ences selectivity. However, the hexitol moiety has a variable
effect on the selectivity of isoCMe :isoG base pairing (Table 4).
An improvement of selectivity with the KF (exo-) was seen
while a reduction was seen with Vent (exo-) and T4 (exo-). With
Pfu (exo-), no effect on selectivity was observed.
To further understand the effect that hexitol sugar could
have on isoCMe :isoG base-pairing system, we investigated the
incorporation of d-isoGMP and d-AMP, using the respective tri-
phosphates as reagents, opposite both deoxyribose and hexi-
tol-isoCMe nucleotides in the template. Two primed (P1) tem-
plates (T2 and T3) were used in these experiments and the re-
sults are shown in Table 5. When hexitol was used instead of
deoxyribose, tests with Pfu (exo-), Vent (exo-) and KF (exo-)
demonstrated a negative effect on selectivity. On the other
hand, the T4 (exo-) DNA polymerase shows no discrimination
between dATP and d-isoGTP as a substrate; both are incorpo-
rated to equal extents regardless of the sugar moiety used. We
suspected that the high degree of dAMP incorporation oppo-
site isoCMe may be due to the deamination of isoCMe to T. This
notion was already suggested by the group of Steven
Benner.[10] They showed that 15% of the oligonucleotides con-
tained T instead of isoCMe, arising during the synthesis or de-
protection step. However, analysis of our oligonucleotides car-
rying deoxyribose and hexitol-isoCMe nucleotides did not show
any deamination, even with samples of 2 years old. With de-
amination excluded, it seems that isoCMe pairs mainly with A,
most likely through a wobble base pair.[31]
HNA-dependent DNA synthesis in vivo
We investigated the roles of sugar modification/deoxyribose
and hexitol scaffold affecting base-pairing recognition and se-
lectivity during xenobiotic HNA-dependent DNA synthesis in
vivo. To develop a successful orthogonal genetic system there
Figure 4. Phosphorimage of the enzymatic incorporation of 500 mm of 2) d-
isoGTP into hybrid P1:T5 (3 d-isoCMe) and 3) h-isoGTP into hybrid P1:T6 (3 h-
isoCMe) using 0.08 UmL¢1 of Pfu (exo-) and KF (exo-). 0.08 UmL¢1 of TIPP was
included. 1 represents the incorporation of 20 mm dGTP into hybrid P1:T4
(dC) (positive control). Reaction time is 60 min.
Table 4. Quantitative data for the incorporation of dTMP and d-isoCMeMP
opposite both d-isoG (P1:T8) and h-isoG (P1:T9) nucleotides in the tem-
plate using both Vent (exo-) and KF (exo-) DNA polymerases.[a]
Vent (exo-) KF (exo-)
dTTP [% d-isoCMeTP [%] dTTP [%] d-isoCMeTP [%]
d-isoG 27.8 60.1 46.3 74
h-isoG 83.5 85.1 17.7 75.1
[a] The above values correspond to the % of extended primer using
0.5 mm of dTTP or d-isoCMeTP, 0.04 UmL¢1 and 0.02 U/mL for Vent (exo-)
and KF (exo-) respectively and 0.08 UmL¢1 of TIPP. Reaction time is 2 min.
Table 5. Quantitative data for the incorporation of dAMP and deoxy-
isoGMP opposite both d-isoCMe (P1:T2) and h-isoCMe (P1:T3) nucleotides in
the template using both Pfu (exo-) and T4 (exo-) DNA polymerases.[a]
Pfu (exo-) T4 (exo-)
dATP [%] d-isoGTP [%] dATP [%] d-isoGTP [%]
d-isoCMe 5.25 21.3 78.3 74.15
h-isoCMe 39.65 84.2 72.8 67.95
[a] The above values correspond to the% of extended primer using
20 mm (for T4 (exo-)) or 200 mm (for Pfu (exo-)) of dATP or d-isoGTP,
0.08 UmL¢1 of Pfu (exo) and T4 (exo-) and 0.08 UmL¢1 of TIPP. Reaction
time is 1 for T4 (exo-) or 10 min for Pfu (exo-).
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should be minimal cross-recognition with natural bases, as
well as specific recognition of partner bases. Accordingly, we
studied the capability of templates containing the xenobiotic
isoCMe and isoG nucleosides in vivo, using the gapped vector
assay through incorporation of sixteen DNA base/modified
base mosaic oligomers (O1–O16, Table 6) to modify genetically
E. coli cells. Oligomers were ligated into the gapped active site
of the E. coli thyA gene located on a plasmid vector (ampicillin
resistance gene bla+ containing pAK1/pAK2 heteroduplex),
before transformation into a thyA¢ strain of E. coli—a lethal
genotype in thymidine deficient media.[23,24]
Ligation of these oligomers into the heteroduplex plasmid
completes the gapped thyA gene. Subsequent DNA synthesis
will replicate the plasmid (and the gene), which can potentially
restore vitality to the strain (permitting survival without sup-
plemental thymidine) should a functional sequence be made.
The assay grants selection and quantification of the cellular in-
terpretation of the h- and d-isoG/isoCMe nucleosides. The base-
pairing of a natural base with the modified nucleoside in the
oligomers during DNA synthesis will cause the replacement of
its equivalent partner. As a result, whatever the nucleoside is
identified as by the system is what will be placed in its posi-
tion in subsequent generations. The h- and d-isoG nucleosides
were incorporated into oligomers in positions encoding G*CG,
T*GC, TGC* and CA*T of the wild-type thyA active site, normally
yielding Ala, Cys, Cys and His, respectively. The TGC-encoded
cysteine is essential for ThyA activity. With these selections, h-
and d-isoG have replaced each natural base (A, T, G, C). The re-
sponse of the in vivo screen follows (Figure 5).
The E. coli DNA synthesis machinery appear to identify d-
isoG as a G (oligomer O2: G*CG) and an A (O8: CA*T) residue,
but not a T or C (in O4: T*GC/O6: TGC*). The TGC codon in
both oligomers codes for the active site Cys residue—an es-
sential amino acid in the enzyme that results in a lethal pheno-
type when changed.[23,24] It is therefore likely that d-isoG is
being strongly recognised as an A and less so a G whilst also
being not recognised as a T or C as any recognition for these
latter bases would recover a non-lethal phenotype. The re-
sponse of the equivalent hexitol scaffold nucleosides follows
largely the same pattern—higher recognition as A then G, and
not at all as T or C, although proportionally the hexitol scaffold
is far less recognised.
This demonstrates that the modifications of the backbone
from deoxyribose to hexitol increases the potential orthogonal-
ity of the isoG base, as the hexitol backbone further reduces
the recognition of isoG by the natural nucleosides. In both
cases, there seems to be a distinct lack of recognition as T and
C which indicates that isoG is not base pairing with A/G, but
instead with T primarily, with both backbone scaffolds. IsoG
gives a mispairing order of T>C@A=G, matching well the in
vitro findings.
The h- and d-isoCMe nucleosides were also studied, through
incorporation into mosaic oligomers which encode T*GC,
TGC*, TGC* C*AT and T*GC CAT* of the thyA active site, natu-
rally yielding the essential Cys in all TGC codons and His in the
CAT codons. Here, h- and d-isoCMe have replaced single or
double T and/or C bases in the oligomers (Figure 6).
In common to previous data, the recognition of hexitol scaf-
fold nucleosides is generally reduced in comparison to deoxyri-
bose scaffold nucleosides. The d-isoCMe nucleoside appears to
be recognised mostly as a C and then T, agreeing with the pre-
vious in vitro data showing the base pairing of this nucleoside
with G most strongly, although in both double incorporations
Table 6. Sequence of the oligomers used in the HNA-dependent DNA
synthesis experiments.
Sequence (5’ 3’)
O1, O2 P-CTA X*CG CCG TGC CAT GCA
(X*=h-isoG, d-isoG for O1, O2, respectively)
O3, O4, O9,
O10
P-CTA GCG CCG X*GC CAT GCA
(X*=h-isoG, d-isoG, h-isoCMe, d-isoCMe for O3, O4, O9,
O10, respectively)
O5, O6, O11,
O12
P-CTA GCG CCG TGX* CAT GCA
(X*=h-isoG, d-isoG, h-isoCMe, d-isoCMe for O5, O6, O11,
O12, respectively)
O7, O8 P-CTA GCG CCG TGC CX*T GCA
(X*=h-isoG, d-isoG for O7, O8, respectively)
O13, O14 P-CTA GCG CCG TGX* X*AT GCA
(X*=h-isoCMe, d-isoCMe for O13, O14, respectively)
O15, O16 P-CTA GCG CCG X*GC CAX* GCA
(X*=h-isoCMe, d-isoCMe for O15, O16, respectively)
Figure 5. Response of the ligation of h-isoG (O1, O3, O5, O7) and d-isoG (O2, O4, O6, O8) containing oligomers into the gapped vector as a function of restor-
ing the essential thymidylate synthase (thyA) gene. The ratio is taken from the number of thymidine-prototrophic colonies (bla+ thyA+) within the total
number of colonies (bla+ thyA¢ plus bla+ thyA+) as an average of experimental repeats. The modified part of the oligomer sequence is shown with the posi-
tion of the h- and d-isoG nucleotides highlighted.
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(TGC* C*AT and T*GC CAT*) there was virtually no recognition
even as a C (for pairing with G). It would seem that double in-
corporations are terminal in this system, and are not able to
be recognised correctly to permit survival as both T and C resi-
dues. The results from the single incorporation hexitol scaffold
isoCMe follow generally the pattern of the deoxyribose forms
but with lower responses, with the exception of the double in-
corporation oligomer (T*GC CAT*), which is the only oligomer
of those tested where there is apparently higher recognition of
the hexitol scaffold relative to deoxyribose. Interpretation of
this result against the single incorporations T*GC and TGC*
and the double incorporation TGC* C*AT suggest that even if
the h- and d-isoCMe nucleosides are mainly base-pairing G
(thus being recognised as C) the presence of two adjacent
molecules will corrupt this recognition. For both h- and d-
isoCMe, the survival phenotype is lethal when two of the nu-
cleosides are adjacent.
With these results considered, it was interesting to observe
what bases may would have been included in the site of the
h- and d-isoG/isoCMe incorporations, as some of the modified
codons had permissible encoding redundancies. Thus, colonies
that were positive for growth in the absence of thymidine
(bla+ thyA+) were confirmed twice by restreaking, before plas-
mid extraction and sequencing. Sequence data from the re-
gions of interest are analysed below (Table 7).
With the h- and d-isoCMe bases, the only changes observed
were found in the codons encoding the essential active site
Cys (T*GC and TGC*). In the former, only T is acceptable, and
from the surviving cells only a T was recovered in this position
for both bases. In the latter, it was found that for d-isoCMe
there was the conversion of the C to a T, confirming more
stable pairing with A than G, which occurred at higher per-
centage rates than with h-isoCMe. Both C and T are permissible
here, as it must encode unconditionally Cys (TGC or TGT). In
the His encoding position (C*AT) no changes were found,
which indicated some recognition of the bases as G, although
for both nucleosides their incorporation here was deleterious
to the survival. It is not yet known what changes to the C*AT
(His) motif affect survival, and the extent of what other amino
acids are tolerable in this position. Recognition of d-isoCMe as T
(base pairing A) is greater than for h-isoCMe, indicated by both
the in vivo response as well as sequencing data.
The h- and d-isoG bases showed a wider range of changes.
In particular there was strikingly strong recognition and resul-
tant misincorporation caused by d-isoG, causing full conversion
of G to A in the Ala codon G*CG—changing the amino acid to
Thr, resulting in approximately half of the survival rate com-
Figure 6. Response of the ligation of h-isoCMe (O9, O11, O13, O15) and d-isoCMe (O10, O12, O14, O16) containing oligomers into the gapped vector as a func-
tion of restoring the essential thymidylate synthase (thyA) gene. The ratio is taken from the number of thymidine-prototrophic colonies (bla+ thyA+) against
the total number of colonies (bla+ thyA¢ and bla+ thyA+) as an average of experimental repeats. The modified part of the oligomer sequence is shown with
the position of the incorporated h- and d-isoCMe nucleotide/s highlighted.
Table 7. Sequences of modified codons recovered by DNA sequencing of
plasmids from thyA+ strains.[a]
Vent (exo-) KF (exo-)
Wild-type codon h-isoCMe d-isoCMe h-isoG d-isoG
T*GC 100%
T*GC (Cys)
100%
T*GC (Cys)
100%
T*GC (Cys)
lethal
TGC* 18%
TGT* (Cys)
82%
TGC* (Cys)
100%
TGT* (Cys)
13%
TGT* (Cys)
87%
TGC* (Cys)
lethal
TGC* C*AT 13%
TGT* (Cys)
87%
TGC* (Cys)
58%
TGT* (Cys)
42%
TGC* (Cys)
N/A N/A
TGC* C*AT 100%
C*AT (His)
100%
C*AT (His)
N/A N/A
T*GC CAT* 100%
T*GC (Cys)
100%
T*GC (Cys)
N/A N/A
T*GC CAT* 100%
CAT* (His)
100%
CAT* (His)
N/A N/A
G*CG N/A N/A 7%
C*CG (Pro)
7%
A*CG (Thr)
86%
G*CG (Ala)
100%
A*CG (Thr)
CA*T N/A N/A 100% CA*T (His) 100%
CA*T (His)
T*GC 100%
*GC (Cys)
100%
T*GC (Cys)
100%
T*GC (Cys)
lethal
[a] Percentages came from the occurrence of the sequence relative to the
number of colonies (bla+ thyA+) analysed (typically 16 as minimum). The
sequence at the site of incorporation in the oligomer is shown, with the
codon under sequence analysis underlined. Deviations from wild-type se-
quence are bolded and the amino acid coded by the codon (unchanged
or otherwise) is indicated in all cases.
Chem. Eur. J. 2015, 21, 5009 – 5022 www.chemeurj.org Ó 2015 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim5016
Full Paper
pared to the ratio of the positive controls. In contrast, the h-
isoG sample population showed some change from G to A, as
well as to C (encoding Pro, CCG), although it was dominantly
recognised as the wild-type G, and in vivo recognition was
low.
Conclusions
We have developed an efficient route for the synthesis of oli-
gonucleotides containing h-isoG and h-isoCMe nucleotides syn-
thesised on solid-phase support by using phosphoramidite
building blocks 13 and 25, respectively. The required h-isoG
phosphoramidite 13 was obtained by nucleophilic displace-
ment of 2-aminoadenine on 2-O-tosylate of 1,5-anhydro-4,6-O-
benzylidene-d-glucitol 7 followed by selective deamination
and usual protection with DMTr and phosphitylation. The ami-
dite of h-isoCMe 25 has been synthesised from commercially
available 1,5:2,3-dianhydro-4,6-O-benzylidene-d-allitol, through
the formation of an intermediate anhydro sugar 18 that was
regioselectively opened with ammonia as a key step. The base-
pairing and mismatch discrimination of hexitol-isoG and hexi-
tol-isoCMe in duplex DNA with antiparallel chain orientation
was determined by Tm measurements. The h-isoG and h-isoC
Me
base-pair engrafted in a double-strand DNA was found to be
less stable compared d-isoG:d-isoCMe (DTm=¢3.6) base pair,
which might be due to the comparison of a mixed backbone
duplex (HNA/DNA) versus a fully DNA duplex. Incorporation of
a h-isoG:h-isoCMe base pair within a fully HNA duplex should
therefore be investigated. The base-pair stability of h-isoG de-
creases in the order d-isoCMeh-isoCMe>GC@T>A, where-
as for d-isoG is d-isoCMe>h-isoCMe>T>G>C@A. The HNA
sugar showed slightly better mismatch discrimination against
dT and increased the selectivity opposite to h-isoCMe compared
to deoxyribose sugar. The incorporation studies have shown
that a hexitol scaffold carrying an isoCMe :isoG base pair can be
recognised and incorporated by a selection of polymerases,
most favourably the Family B DNA polymerases. However, in-
corporation of more than two nucleotides with hexitol nucleic
acids was not possible.[3a] Sugar modifications may influence
the selectivity of a base pair. However, this alteration is poly-
merase-dependent. Our selected sugar, hexitol, is capable of
both improving and reducing the selectivity of the isoCMe :isoG
base pair. Thus altering the sugar moiety does not seem like
being a generic solution for improving the isoCMe :isoG base-
pairing selectivity. The in vivo and sequencing experiments
show the base-pair stabilities of the h- and d-isoG/CMe nucleo-
tides in a genetic context. The penalty to cell survival in the
screens was proportional to the level of recognition of the nu-
cleosides as the natural bases. This was established through
the in vivo stabilities of base pairing made by the incorporated
nucleotides, and as suggested by the in vitro data obtained,
this would also depend on the nature of the polymerase. Lim-
ited codon redundancies in some positions exposed silent
changes in the structure of the genetic code of the thyA gene,
as well as in the translated enzyme, whereas others generated
codon and subsequent amino acid modifications that affected
survival response. The role of the hexitol scaffold showed po-
tency for loss of recognition compared to the deoxyribose
scaffold, demonstrating further steps towards orthogonality
(which seems to be reached with the double h-isoCMe incorpo-
ration experiment) that will encourage and inspire future de-
velopments towards an orthogonal XNA-based information
system.
Experimental Section
1H, 13C and 31P NMR spectra were recorded on 300 (1H, 300; 13C, 75;
31P NMR, 121 MHz), 500 (1H, 500; 13C NMR, 125 MHz), or 600 MHz
(1H, 600; 13C NMR, 150 MHz) spectrometers. 2D NMRs (H-COSY,
HSQC and HMBC) were used for the assignment of all the inter-
mediates and final compounds. Mass spectra were acquired on
a quadrupole orthogonal acceleration time-of-flight mass spec-
trometer. Column chromatographic separations were carried out
by gradient elution with suitable combination of two/three sol-
vents and silica gel (100–200 mesh or 230–400 mesh). Solvents for
reactions were distilled prior to use: THF and toluene from Na/ben-
zophenone; CH2Cl2 and CH3CN from CaH2 ; Et3N and pyridine from
KOH.
1’,5’-Anhydro-4’,6’-O-benzylidene-2’,3’-dideoxy-2’-(2,6-diami-
nopurin-9-yl)-d-arabino-hexitol (8)
A mixture of 2,6-diaminopurine (2.3 g, 15.37 mmol) and sodium hy-
dride 60% in mineral oil (409 mg, 10.24 mmol) in anhydrous DMF
(20 mL) was stirred at room temperature for 30 min under nitro-
gen. Then, the tosylate sugar 7 (2.0 g, 5.12 mmol) was added. The
temperature was raised up to 90 8C and stirring was continued for
12 h. The reaction mixture was then cooled and evaporated to dry-
ness. The residue was dissolved in ethyl acetate (100 mL), and the
organic layer was washed with a saturated solution of NaHCO3 (3Õ
30 mL). The organic layer was dried over sodium sulphate, filtered
and evaporated to dryness. The crude material was purified by
flash column chromatography on silica gel (CH2Cl2/MeOH, 20:1) to
give 8 (1.5 g, 79%) as a white solid. UV (MeOH): lmax=256,
283 nm; 1H NMR (600 MHz, [D6]DMSO): d=7.88 (s, 1H, H8), 7.38–
7.33 (m, 5H, Ar-H), 6.77 (s, 2H, NH2), 5.88 (s, 2H, NH2), 5.63 (s, 1H,
PhCH), 4.65 (br s, 1H, H2’), 4.35 (d, J=13.2 Hz, H1b’), 4.21 (dd, J=
10.3, 4.9 Hz, 1H, H6b’), 4.05 (dd, J=13.2, 2.7 Hz, 1H, H1a’), 3.78 (t,
J=10.3 Hz, 1H, H6a’), 3.72 (ddd, J=12.6, 9.7, 4.3 Hz, 1H, H4’), 3.50
(td, J=9.7, 4.9 Hz, 1H, H5’), 2.42 (m, 1H, H3b’), 2.07 ppm (td, J=8.5,
4.3 Hz, 1H, H3a’) ;
13C NMR (151 MHz, [D6]DMSO): d=160.3 (C6),
156.2 (C2), 151.6 (C4), 137.7 (Ipso), 135.7 (C8), 128.7, 127.9 (s), 126.1
(s) (Ar-C), 112.8 (C5), 100.8 (PhCH), 73.7 (C5’), 73.4 (C4’), 68.9 (C1’),
68.0 (C6’), 49.6 (C2’), 32.1 ppm (C3’) ; HRMS (ESI+): calcd for
C18H20N6O3 : 369.1669 [M+H]
+ ; found: 369.1669.
1’,5’-Anhydro-2’,3’-dideoxy-2’-(2,6-diaminopurin-9-yl)-d-ara-
bino-hexitol (9)
A solution of compound 8 (1.3 g, 3.53 mmol) in CH3COOH/H2O
(40 mL, 6:4) was stirred at 60 8C for 4 h. The mixture was evaporat-
ed under reduced pressure and co-evaporated with toluene. The
crude material was purified by flash column chromatography
(CH2Cl2/MeOH, 9:1) to give 9 (903 mg, 91%) as a white solid. UV
(MeOH): lmax=256, 281 nm.
1H NMR (500 MHz, [D6]DMSO): d=7.91
(s, 1H, H8), 6.71 (s, 2H, NH2), 5.84 (s, 2H, NH2), 4.56 (s, 1H, H2’), 4.13
(d, J=12.5 Hz 1H, H1b’), 3.81 (dd, J=12.5, 2.4 Hz 1H, H1a’), 3.69 (dd,
J=11.5, 1.3 Hz 1H, H6b’), 3.58 (dd, J=11.5, 4.9 Hz 1H, H6a’), 3.51 (td,
J=6.0, 4.8 Hz 1H, H4’), 3.14–3.19 (m, 1H, H5’), 2.20–2.26 (m, 1H,
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H3b’), 1.81 ppm (td, J=13.2, 4.8 Hz 1H, H3a’) ;
13C NMR (125 MHz,
[D6]DMSO): d=160.2 (C6), 156.1 (C2), 151.6 (C4), 136.2 (C8), 112.6
(C5), 83.0 (C5’), 68.1 (C1’), 60.8 (C5’), 60.5 (C6’), 49.3 C2’), 36.0 ppm
(C3’) ; HRMS (ESI+): calcd for C11H16N6O3 : 281.1356 [M+H]
+ ; found:
281.1360.
1’,5’-Anhydro-2’,3’-dideoxy-2’-(6-amino-2-hydroxy-purin-9-
yl)-d-arabino-hexitol (2)
The diamino compound 9 (800 mg, 2.85 mmol) was suspended in
H2O (20 mL) at 55 8C and a solution of NaNO2 (768 mg,
11.13 mmol) in H2O (5 mL) was added dropwise. Then AcOH
(1.1 mL, 19.98 mmol) was added over 2 min. The resulting clear so-
lution was stirred for 10 min, then cooled to room temperature
and diluted with H2O (15 mL), and conc. aq. NH3 solution was
added to adjust the pH 8. The solution was evaporated and the re-
maining solid was washed with H2O to give a yellow solid. The
crude material was purified by flash column chromatography
(CH2Cl2/MeOH, 3:1) to give 2 (612 mg, 76%) as a yellow solid. UV
(MeOH): lmax=249, 298 nm;
1H NMR (600 MHz, [D6]DMSO): d=7.94
(s, 1H, H8), 4.90 (d, J=4.9 Hz, 1H, OH), 4.64 (br s, 1H, H2’), 4.52 (s,
1H, OH), 4.09 (d, J=12.6 Hz, 1H, H1b’), 3.79 (d, J=12.6, 2.6 Hz, 1H,
H1a’), 3.68 (d, J=11.6 Hz, 1H, H6b’), 3.59–3.54 (m, 1H, H6a’), 3.53–
3.48 (m, 1H, H4’), 3.18–3.13 (m, 1H, H5’), 2.21–2.17 (m, 1H, H3b’),
1.82–1.76 ppm (m, 1H, H3a’) ;
13C NMR (75 MHz, [D6]DMSO): d=
156.5, 156.4 (C2, C6), 152.2 (C4), 138.1 (C8), 108.7 (C5), 83.1 (C5’),
68.1 (C1’), 60.8, 60.6 (C4’, C6’), 49.5 (C2’), 35.9 ppm (C3’) ; HRMS
(ESI+): calcd for C11H15N5O4 : 282.1196 [M+H]
+ ; found: 282.1197.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-(dimethylamino)methyl-
idene-2-hydroxy-purin-9-yl]-d-arabino-hexitol (10)
N,N-Dimethylformamide dimethyl acetal (1.1 mL, 2.2 mmol) was
added to a suspension of 2 (500 mg, 1.7 mmol) in MeOH (20 mL),
and the resulting mixture stirred at 25 8C for 12 h. The reaction
mixture was evaporated to dryness and purified by flash column
chromatography (CH2Cl2/MeOH, 4:1) to give 10 (480 mg, 80%) as
a white solid. UV (MeOH): lmax=262, 345 nm;
1H NMR (600 MHz,
[D6]DMSO): d=9.21 (s, 1H, N=CH), 8.08 (s, 1H, H8), 4.54 (s, 1H, H2’),
4.10 (d, J=12.6 Hz, 1H, H1b’), 3.81 (dd, J=12.6, 2.3 Hz, 1H, H1a’),
3.67 (dd, J=11.8, 1.98 Hz, 1H, H6b’), 3.59 (dd, J=11.8, 4.5 Hz, 1H,
H6a’), 3.51 (ddd, J=11.0, 9.4, 4.9 Hz, 1H, H4’), 3.20 (s, 3H, NCH3),
3.18–3.15 (m, 1H, H5’), 3.09 (s, 3H, NCH3), 2.24–2.18 (m, 1H, H3b’),
1.83–1.76 ppm (m, 1H, H3a’) ;
13C NMR (150 MHz, [D6]DMSO): d=
161.4 (N=C), 157.4 (C4), 156.7 (C2), 154.3 (C6), 140.7 (C8), 112.4
(C5), 83.0 (C5’), 67.9 (C1’), 60.5 (C4’), 60.4 (C-6’), 49.4 (C2’), 41.1 (N-
CH3), 35.6 (C3’), 34.3 ppm (N¢CH3) ; HRMS (ESI+): m/z : calcd for
C14H20N6O4 : 337.1618 [M+H]
+ ; found: 337.1619.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-N-(dimethylamino)methyl-
idene-2-O-(diphenyl-carbamoyl)purin-9-yl]-d-arabino-hexitol
(11)
Diphenylcarbamoyl chloride (350 mg, 1.04 mmol) and N,N-diisopro-
pylethylamine (0.71 mL, 1.35 mmol) was successively added to
a suspension of 10 (350 mg, 1.04 mmol) in dry pyridine (15 mL).
The reaction mixture was stirred for 1 h at 25 8C. Then, the mixture
was poured into 5% aqueous solution NaHCO3 (10 mL) and ex-
tracted with CH2Cl2 (3Õ10 mL). The combined organic layers were
dried over Na2SO4 and filtered. After evaporation of the solvent,
the residue was purified by flash column chromatography (CH2Cl2/
MeOH, 20:1) to give 11 (420 mg, 76%) as a pink solid. UV (MeOH):
lmax=236, 315 nm;
1H NMR (500 MHz, [D6]DMSO): d=8.90 (s, 1H,
N=CH), 8.41 (s, 1H, H8), 7.46–7.40 (m, 8H, ArH). 7.26–7.35 (m, 2H,
ArH), 4.94 (d, J=5.4 Hz, 1H, OH), 4.77 (s, 1H, H2’), 4.68 (t, J=6.2 Hz,
1H, OH), 4.20 (d, J=12.7 Hz, 1H, H1b’), 3.86 (dd, J=12.7, 2.5 Hz, 1H,
H1a’), 3.69 (ddd, J=7.7, 6.2, 2.3 Hz, 1H, H6b’), 3.57–3.56 (m, 1H, H6a’),
3.52 (ddd, J=14.2, 10.4, 5.4 Hz, 1H, H4’), 3.22–3.18 (m, 4H, NCH3,
H5’), 3.13 (s, 3H, NCH3), 2.29–2.24 (m, 1H, H3b’), 1.90 ppm (ddd, J=
13.6, 10.4, 4.15 Hz, 1H, H3a’) ;
13C NMR (125 MHz, [D6]DMSO): d=
160.5 (C6), 158.8 (HC=N), 155.3 (C2), 152.5 (C4), 151.6 (C=O), 141.9
(C8), 129.2, 127.1, 126.8 (Ar), 123.0 (C5), 82.9 (C5’), 67.8 (C1’), 60.6
(C4’), 60.4 (C6’), 50.3 (C2’), 40.8 (N-CH3), 35.8 (N-CH3), 34.6 ppm
(C3’) ; HRMS (ESI+): calcd for C27H29N7O5 : 532.2302 [M+H]
+ ; found:
532.2303.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-N-(dimethylamino)methyl-
idene-2-O-(diphenyl-carbamoyl)purin-9-yl]-6’-O-dimethoxy
trityl-d-arabino-hexitol (12)
Compound 11 (1.05 g, 0.75 mmol) was dried by co-evaporation
with pyridine (3Õ10 mL), and was then dissolved in dry pyridine
(20 mL). 4,4’-Dimethoxytrityl chloride (305 mg, 0.90 mmol) was
added in three portions (each every 10 min) at 0 8C under stirring.
The mixture was warmed up to room temperature and stirred for
12 h. After addition of MeOH (5 mL), the reaction mixture was
evaporated and the residue was dissolved in CH2CI2 (50 mL). The
solution was washed with 5% NaHCO3 aqueous solution (10 mL)
and H2O (10 mL), dried over Na2SO4 and the organic layer was
evaporated to afford an oil. The crude material was purified by
flash column chromatography (CH2Cl2/MeOH/TEA, 98:2:1) to give
12 (549 mg, 73%) as a white foam. UV (MeOH): lmax=234, 316 nm;
1H NMR (500 MHz, [D6]DMSO): d=8.98 (s, 1H, N=CH), 8.42 (s, 1H,
H8), 7.44–7.21 (m, 19H, Ar), 6.90–6.86 (m, 4H, Ar), 4.87 (d, J=
5.8 Hz, 1H, OH), 4.77 (s, 1H, H2’), 4.34 (d, J=12.8 Hz, 1H, H1b’), 3.93
(d, J=12.8 Hz, 1H, H1a’), 3.74 (s, 3H, 3CH3), 3.73 (s, 3H, 3CH3),
3.57–3.52 (m, 1H, H4’), 3.12–3.38 (m, 10H, H5’, H6a’, H6b’, 2NCH3),
2.38–2.33 (m, 1H, H3b’), 1.93–1.86 ppm (m, 1H, H3a’) ;
13C NMR
(150 MHz, CDCl3): d=160.8 (C6), 158.8 (C=N), 158.5, 156.0 (C2, Ar),
152.8, 152.2 (C4, C=O), 144.2, 142.1 (Ar), 141.3 (C8), 135.4, 135.4,
129.8, 128.8, 127.9, 127.9, 126.9 (Ar), 123.8 (C5), 113.2 (Ar), 86.8
(CPh3), 80.4 (C4’), 69.1 (C1’), 64.6 (C5’), 55.15 (OCH3), 53.2 (C6’), 50.1
(C2’), 41.3 (NCH3), 35.8 (C3’), 35.2 ppm (NCH3) ; HRMS (ESI+): calcd
for C48H47N7O7: 834.3609 [M+H]
+ ; found: 834.3614.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-N-(dimethylamino)methyl-
idene-2-O-(diphenyl-carbamoyl)purin-9-yl]-6’-O-dimethoxy
trityl-d-arabino-hexitol-4’-(2-cyanoethyl-N,N-diisopropyl)-
phosphoramidite (13)
A 0.45 molar solution of 1H-tetrazole (1.0 mL, 0.47 mmol) was
added dropwise to a mixture of 1m cyanoethyl-bis(N,N-diisopropy-
lamino)phosphine (0.87 mL, 0.87 mmol) and 12 (330 mg,
0.39 mmol) in CH2Cl2 (15 mL) at 0 8C, and the reaction mixture was
allowed to stir at room temperature for 1 h. The reaction mixture
was diluted with CH2Cl2 (40 mL) and washed with 5% NaHCO3
aqueous solution (10 mL). The organic layer was dried over Na2SO4
and concentrated. The crude mixture was quickly purified by flash
column chromatography (n-hexane/acetone/TEA, 50:50:1) to give
diastereomeric mixture 13 (305 mg, 75%) as a white foam. 31P NMR
(202 MHz, CDCl3): d=149.3, 148.5 ppm;
1H NMR (500 MHz, CDCl3):
d=9.02 (s, 1H, N=CH), 8.45 (s, 1H, H8), 7.50–7.19 (m, 19H, Ar),
6.85–6.80 (m, 4H, Ar), 4.91 (s, 1H, H2’), 4.38 (d, J=13.0 Hz, 1H,
H1b’), 4.04–3.97 (m, 1H, H1b’), 3.89–3.78 (m, 7H, 2OCH3, H4’), 3.72–
3.14 (m, 13H, OCH2, H6a’, H6b’, 2NCH3, H5’, 2CHN), 2.69–2.59 (m, 1H,
H3b’), 2.22 (t, J=6.4 Hz, 2H, CH2CN), 2.04–1.90 (m, 1H, H3a’), 1.05
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¢0.81 ppm (m, 12H, 4CH3) ; HRMS (ESI+): calcd for C57H64N9O8P:
1034.4687 [M+H]+ ; found 1034.4692.
1’,5’-Anhydro-4’,6’-O-benzylidene-2’-deoxy-2’-(5-methyl-iso-
cytosin-1-yl)-d-manno-hexitol (19)
A solution of compound 17 (1.0 g, 2.28 mmol) in methanolic am-
monia (saturated at 0 8C, 50 mL) was heated at 160 8C for 60 h in
a sealed tube. After cooling down at room temperature the reac-
tion mixture was concentrated, and the residue was purified by
flash column chromatography (CH2Cl2/MeOH, 20:1) to give 22
(580 mg, 70%) as a white solid. UV (MeOH): lmax=260;
1H NMR
(500 MHz, [D6]DMSO): d=7.73 (s, 1H, H6), 7.49–7.35 (m, 5H, Ar),
5.69 (s, 1H, CHPh), 4.53 (br s, 1H, H2’), 4.22 (dd, J=6.1, 2.9 Hz, 1H,
H6b’), 4.19 (d, J=8.1 Hz, 1H, H1b’), 4.12 (dd, J=5.9, 3.3 Hz, 1H, H3’),
4.04 (dd, J=8.1, 2.1 Hz, 1H, H1a’), 3.85 (t, J=6.1 Hz, 1H, H6a’), 3.78
(t, J=5.9 Hz, 1H, H4’), 3.52 (td, J=5.9, 2.9 Hz, 1H, H5’), 1.80 ppm (s,
1H, CH3) ;
13C NMR (125 MHz, [D6]DMSO): d=170.1 (C4), 157.0 (C2),
137.7 (Ar), 135.7 (C6), 128.9, 128.0, 126.3 (Ar), 114.6 (C5), 101.0
(CPh), 77.7 (C4’), 71.6 (C5’), 68.7 (C3’), 68.3 (C1’), 67.5 (C6’), 57.3
(C2’), 14.1 ppm (CH3) ; HRMS (ESI+): calcd for C18H21N3O5 : 360.1553
[M+H]+ ; found: 360.1555.
1’,5’-Anhydro-4’,6’-O-benzylidene-2’-deoxy-2’-[6-(Dimethyl-
amino)methylidene-5-methyl-isocytosin-1-yl)-d-manno-hexi-
tol (20)
N,N-Dimethylformamide dimethyl acetal (0.37 mL, 2.78 mmol) was
added to a suspension of 19 (500 mg, 1.39 mmol) in MeOH
(20 mL). The reaction mixture was stirred at 65 8C for 3 h. The reac-
tion mixture was evaporated to dryness and purified by flash
column chromatography (CH2Cl2/MeOH, 97:3) to give 20 (510 mg,
88%) as a white solid. UV (MeOH): lmax=247, 280 nm;
1H NMR
(500 MHz, CDCl3): d=8.82 (s, 1H, N=CH), 7.97 (s, 1H, H6), 7.50–7.30
(m, 5H, Ar), 5.63 (s, 1H, CHPh), 5.26–5.22 (m, 1H, H2’), 4.37 (dd, J=
6.3, 2.9 Hz, 1H, H6b’), 4.34 (dd, J=5.8, 3.2 Hz, 1H, H3’), 4.27 (d, J=
8.3 Hz, 1H, H1b’), 4.06 (dd, J=8.3, 2.1 Hz, 1H, H1a’), 3.85 (t, J=
6.3 Hz, 1H, H6a’), 3.79 (t, J=6.3 Hz, 1H, H4’), 3.58 (td, J=5.8, 2.9 Hz,
1H, H5’), 3.18 (s, 3H, NCH3), 3.06 (s, 3H, NCH3), 2.05 ppm (s, 3H,
CH3) ;
13C NMR (126 MHz, CDCl3): d=171.7 (C4), 159.2 (C2), 158.9 (C=
N), 137.1 (Ar), 136.3 (C6), 129.2, 128.3, 126.4 (Ar), 119.0 (C5), 102.2
(CHPh), 78.3 (C4’), 72.2 (C5’), 71.3 (C3’), 68.5, 68.2 (C6’, C1’), 56.8
(C2’), 41.9, 35.8 (NCH3), 14.6 ppm (CH3) ; HRMS (ESI+): calcd for
C21H26N4O5 : 415.1975 [M+H]
+ ; found: 415.1978.
1’,5’-Anhydro-4’,6’-O-benzylidene-3-O-(imidazol-1-ylthiocar-
bonyl)-2’-deoxy-2’-[6-(di-methylamino)methylidene-5-
methyl-isocytosin-1-yl)-d-manno-hexitol (21)
1,1’-Thiocarbonyldiimidazole (316 mg, 1.77 mmol) was added to
a solution of compound 20 (490 mg, 1.18 mmol) in DMF. The reac-
tion mixture was stirred for 12 h at room temperature. The reaction
mixture was diluted with ethyl acetate (100 mL) and washed with
H2O (3Õ10 mL). The organic layer was dried over Na2SO4 and
evaporated. The residue was purified by flash column chromatog-
raphy (CH2Cl2/MeOH, 97:3) to give 21 (549 mg, 88%) as a yellow
solid. UV (MeOH): lmax=247, 280 nm;
1H NMR (500 MHz, CDCl3):
d=8.26 (s, 1H, CH=N), 8.24 (s, 1H, Im-H), 8.07 (s, 1H, H6), 7.42–7.30
(m, 5H, Ar), 7.23 (s, 1H, Im-H), 6.98 (s, 1H, Im-H), 6.43 (dd, J=10.5,
5.5 Hz, 1H, H3’), 5.87 (dd, J=5.5, 3.5 Hz, 1H, H2’), 5.61 (s, 1H,
CHPh), 4.47–4.40 (m, 2H, H6b’, H1b’), 4.25 (dd, J=13.9, 3.5 Hz, 1H,
H1a’), 4.18 (dd, J=10.5, 9.6 Hz, 1H, H4’), 3.92 (t, J=10.5 Hz, 1H,
H6a’), 3.77 (td, J=9.6, 4.9 Hz, 1H, H5’), 2.90 (s, 3H, NCH3), 2.82 (s,
3H, NCH3), 2.09 ppm (s, 3H, CH3) ;
13C NMR (125 MHz, CDCl3): d=
183.8 (C=S), 171.4 (C4), 159.0 (C2), 158.6 (C=N), 138.3 (Im-C), 136.4
(Ar), 135.8 (C6), 131.3 (Im-C), 129.4, 128.3, 126.2 (Ar), 118.7 (Im-C),
116.8 (Im-C), 102.1 (CHPh), 78.1 (C3’), 74.9 (C4’), 73.0 (C5’), 69.1
(C1’), 68.4 (C6’), 52.5 (C2’), 41.4 (NCH3), 35.4 (NCH3), 14.7 ppm (CH3) ;
the HRMS analysis showed degradation of 21 to compound 20.
1’,5’-Anhydro-4’,6’-O-benzylidene-2’,3’-dideoxy-2’-[6-(dime-
thylamino)methylidene-5-methyl-isocytosin-1-yl]-d-arabino-
hexitol (22)
nBu3SnH (0.81 mL, 3.03 mmol) was added at room temperature to
a solution of 21 (510 mg, 1.01 mmol) and AIBN (82 mg. 0.50 mmol)
in anhydrous and degassed toluene (40 mL). This solution was de-
gassed three times under argon. The reaction mixture was heated
at 80 8C for 3 h. The volatile was evaporated under reduced pres-
sure, and the residue was purified by flash column chromatogra-
phy (CH2Cl2/MeOH, 97:3) to give 22 (280 mg, 89%) as a thick
liquid. UV (MeOH): lmax=247, 282 nm;
1H NMR (500 MHz, CDCl3):
d=8.86 (s, 1H, CH=N), 7.87 (s, 1H, H6), 7.47–7.33 (m, 5H, Ar), 5.59
(s, 1H, CHPh), 5.08 (br s, 1H, H2’), 4.36 (dd, J=10.6, 4.9H, 1H, H6b’),
4.31 (d, J=13.7 Hz, 1H, H1b’), 4.01(dd, J=13.7, 3.6 Hz, 1H, H1a’),
3.81 (t, J=10.6 Hz, 1H, H1a’), 3.71–3.77 (m, 1H, H4’), 3.54–3.46 (m,
1H, H5’), 3.14 (s, 1H, NCH3), 3.05 (s, 1H, NCH3), 2.57–2.51 (m, 1H,
H3b’), 1.99–2.09 ppm (m, 4H, CH3, H3a’) ;
13C NMR (75 MHz, CDCl3):
d=172.4 (C4), 158.8 (C=N), 157.9 (C2), 137.2 (Ar), 136.3 (C6), 129.2,
128.4, 126.1 (Ar), 117.7 (C5), 102.1 (CHPh), 74.3, 73.7 (C4’, C5’), 69.1,
69.0 (C6’, C1’), 53.2 (C2’), 41.3, 35.2 (NCH3), 33.7 (C3’), 14.6 ppm
(CH3) ; HRMS (ESI+): calcd for C21H26N4O4 : 399.2026 [M+H]
+ ; found:
399.2025.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-(dimethylamino)methyl-
idene-5-methyl-isocytosin-1-yl)-d-arabino-hexitol (23)
A solution of compound 22 (470 mg, 1.13 mmol) in acetic acid/
water (20 mL, 6:4) was stirred at 60 8C for 4 h. The mixture was
evaporated under reduced pressure and co-evaporated with tolu-
ene. The crude material was purified by flash column chromatogra-
phy (CH2Cl2/MeOH, 9:1) to give 23 (903 mg, 93%) as a white solid.
UV (MeOH): lmax=247, 282 nm;
1H NMR (500 MHz, CD3OD): d=
8.65 (s, 1H, CH=N), 8.19 (s, 1H, H6), 5.12 (br s, 1H, H2’), 4.24 (d, J=
13.6 Hz, 1H, H1b’), 3.92 (dd, J=13.6, 3.5 Hz, 1H, H1a’), 3.84 (dd, J=
12.0, 9.6 Hz, 1H, H6b’), 3.77 (dd, J=12.0, 5.0 Hz, 1H, H6a’), 3.70–3.66
(m, 1H, H4’), 3.32–3.22 (m, 1H, H5’), 3.21 (s, 3H, NCH3), 3.13 (s, 3H,
NCH3), 2.37 (d, J=13.6 Hz, 1H, H3b’), 1.94 (s, 3H, CH3), 1.84–
1.92 ppm (m, 1H, H3a’) ;
13C NMR (125 MHz, CD3OD): d=174.7 (C4),
160.1 (C=N), 159.9 (C2), 140.2 (C6), 117.2 (C5), 83.9 (C5’), 69.0 (C1’),
62.4 (C4’), 62.3 (C6’), 54.9 (C2’), 41.5 (NCH3), 37.2 (NCH3), 35.4 (C3’),
14.1 ppm (CH3) ; HRMS (ESI+): calcd for C14H22N4O4 : 311.1713
[M+H]+ ; found: 311.1714.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-(dimethylamino)methyli-
dene-5-methyl-isocytosin-1-yl]-6’-O-dimethoxytrityl d-arabi-
no-hexitol (24)
Reaction of compound 23 (300 mg, 0.96 mmol) with 4,4’-dimethox-
ytrityl chloride (360 mg, 1.06 mmol) in dry pyridine (20 mL) was
carried out as described for compound 12 and purified by flash
column chromatography (CH2Cl2/MeOH/TEA, 97:3:1) to give 24
(520 mg, 88%) as a white foam. UV (MeOH): lmax=236, 282 nm;
1H NMR (500 MHz, [D6]DMSO): d=8.82 (s, 1H, CH=N), 8.02 (s, 1H,
H6), 7.45–7.27 (m, 9H, Ar), 6.81–6.86 (m, 4H, Ar), 5.05 (br s, 1H, H2’),
4.23 (d, J=13.5 Hz, 1H, H1b’), 3.95 (m, 1H, H4’), 3.85 (dd, J=13.5,
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3.5 Hz, 1H, H1a’), 3.78 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.47 (dd, J=
10.2, 4.0 Hz, 1H, H6b’), 3.41 (dd, J=10.2, 4.0 Hz, 1H, H6a’), 3.36–3.29
(m, 1H, H5’), 3.13 (s, 3H, NCH3), 3.06 (s, 3H, NCH3), 2.47–2.39 (m,
1H, H3b’), 1.95 (s, 3H, CH3), 1.86–1.77 ppm (m, 1H, H3a’) ;
13C NMR
(125 MHz, [D6]DMSO): d=172.3 (C4), 158.8, 158.6, 157.9 (Ar, C=N,
C2), 144.6 (C6), 136.6, 135.8, 135.7, 130.0, 128.0, 127.0 (Ar), 117.5
(C5), 113.3 (Ar), 86.5 (CPh3), 80.9 (C5’), 68.6 (C1’), 63.5, 63.3 (C4’,
C6’), 55.3 (OCH3), 52.7 (C2’), 41.2, 36.1 (NCH3), 35.1 (C3’), 14.6 ppm
(CH3) ; HRMS (ESI+): calcd for C35H40N4O6 : 613.3020 [M+H]
+ ; found:
613.3027.
1’,5’-Anhydro-2’,3’-dideoxy-2’-[6-(dimethylamino)methyl-
idene-5-methyl-isocytosin-1-yl)-6’-O-dimethoxytrityl-d-arabi-
no-hexitol-4’-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
(25)
Reaction of 24 (300 mg, 0.96 mmol) with 1m cyanoethyl-bis(N,N-
diisopropylamino) phosphine (0.97 mL, 0.97 mmol) and 1H-tetra-
zole (1.20 mL, 0.53 mmol) in dry CH2Cl2 (15 mL) was carried out as
described for 13 and purified by flash column chromatography (n-
hexane/acetone/TEA, 60:40:1) to give diastereomeric mixture 25
(325 mg, 81%) as a white foam. 31P NMR (121 MHz, CDCl3): d=
148.4, 148.1 ppm; 1H NMR (500 MHz, CDCl3): d=8.85 (s, 1H, CH=N),
8.07 (s, 1H, H6), 7.49–7.20 (m, 9H, Ar), 6.85–6.80 (m, 4H, Ar), 5.06 (s,
1H, H2’), 4.27 (d, J=13.1 Hz, 1H, H1b’), 4.17–4.10 (m, 1H, H4’), 3.95–
3.90 (m, 1H, H1a’), 3.79 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.55–3.23
(m, 7H, H6a’, H6b’, H5’, OCH2, 2NCH), 3.14 (s, 3H, NCH3), 3.05 (s, 3H,
NCH3), 2.50 (brd, J=14.3 Hz, 1H, H3b’), 2.27 (t, J=6.2 Hz, 2H,
CH2CN), 1.93–1.86 (m, 1H, H3a’), 1.82 (s, 3H, CH3), 0.90–1.08 ppm
(m, 12H, 4CH3) ; HRMS (ESI+): calcd for C44H57N6O7P: 813.4098
[M+H]+ ; found: 813.4091.
1’,5’-Anhydro-2’,3’-dideoxy-2’-(isoguanin-1-yl)-d-arabino-hex-
itol-6’-triphosphate-tetrabutylammonium salt (26)
Phosphoryl chloride (20 mL, 0.22 mmol) was added to an ice-cold
solution of protected h-isoCMe 11 (60 mg, 0.11 mmol) in trimethyl-
phosphate (TMP) (1.0 mL) and the solution was stirred at 0 8C for
5 h. Tributylamine (300 mL, 1.6 mmol) and tetrabutylammonium py-
rophosphate solution (0.5m in DMF, 1.1 mmol) was added simulta-
neously, and the solution stirred for a further 30 min. The reaction
was then quenched by the addition of 0.5m triethylammonium bi-
carbonate (TEAB) buffer (10 mL), and stored at 4 8C overnight. The
solvent was evaporated and the residue was treated with 25% am-
monia (4 mL). The solution was evaporated to dryness and re-dis-
solved in water (5 mL) and applied to a Sephadex A25 column in
0.1m TEAB buffer. The column was eluted with a linear gradient of
0.1–1.0m TEAB. Appropriate fractions were pooled and evaporated
to dryness to give desired product. HPLC (Alltima 5m C-18 reverse
phase column 10Õ250 mm, buffer A, 0.1m TEAB; buffer B, 0.1m
TEAB, 25% MeCN. 0% to 100% buffer B over 60 min at 3 mLmin¢1)
showed the product to be pure. 31P NMR (121 MHz, D2O): d=
¢10.21 (1P, d), ¢10.72 (1P,d), ¢23.49 ppm (1P, t); HRMS (ESI): calcd
for C11H18N5O13P3 : 520.0041 [M¢H]¢ ; found: m/z : 520.0043.
1’,5’-Anhydro-2’,3’-dideoxy-5’-acetoxy-2’-[6-(Dimethylamino)-
methylidene-5-methyl-isocytosin-1-yl]-d-arabino-hexitol (27)
Acetic anhydride (91.9 mmL, 972 mmol) was added dropwise, over
one min, at room temperature to a THF (5 mL) solution of com-
pound 24 (149 mg, 243 mmol), 4-methylaminopyridine (11.8 mg,
97.27 mmol), and diisopropylethylamine (251 mg, 1.95 mmol). After
stirring for 20 min, ethyl acetate (20 mL) was added and the solu-
tion was washed with saturated brine (3Õ5 mL). The organic phase
was dried (anhydrous Na2SO4) and solvent removed under vacuum
to yield white foam, which was used directly without further purifi-
cation for the next step. A 2.5% solution of dichloroacetic acid
(3 mL ) was added at 0 8C to a solution of acetylated h-isoCMe in
10 mL of CH2Cl2. The reaction mixture was stirred at room temper-
ature for 10 min. After completion of the reaction (monitored by
TLC), the reaction mixture was diluted with CH2Cl2 (20 mL), and the
organic layer was then washed 2 times with 5 mL of saturated
aqueous NaHCO3. The organic layer was dried over Na2SO4 and
concentrated in vacuum, and the residue was purified by flash
column chromatography (CH2Cl2/MeOH, 95:5) to give 27 (50 mg,
59%) as a white solid. 1H NMR (500 MHz, CD3OD): d=8.67 (s, 1H,
CH=N), 8.15 (s, 1H, H6), 5.12 (br s, 1H, H2’), 4.37 (dd, J=11.9, 2.1 Hz,
1H, H6b’), 4.32 (dd, J=11.9, 4.8 Hz, 1H, H6a’), 4.24 (d, J=13.5 Hz,
1H, H1b’), 3.93 (dd, J=13.5, 3.4 Hz, 1H, H1a’), 3.71–3.63 (m, 1H, H4’),
3.46–3.42 (m, 1H, H5’), 3.22 (s, 3H, NCH3), 3.13 (s, 3H, NCH3), 2.43–
2.37 (m, 1H, H2b’), 2.07 (s, 3H, CH3), 1.96 (s, 3H, CH3), 1.85–
1.92 ppm (m, 1H, H2a’) ;
13C NMR (125 MHz, CD3OD): d=173.2, 171.1
(C4, C=O), 158.7 (C=N), 158.4 (C2), 138.5 (C6), 115.6 (C5), 79.7 (C5’),
67.5 (C1’), 63.0(C6’), 60.9 (C4’), 53.4 (C2’), 40.0 (NCH3), 35.6 (NCH3),
33.9 (C3’), 19.2 (CH3), 12.8 ppm (CH3) ; HRMS (ESI+): calcd for
C16H24N4O5 : 353.1819 [M+H]
+ ; found: 353.1819.
1’,5’-Anhydro-2’,3’-dideoxy-2’-(5-methylisocytosin-1-yl)-d-
arabino-hexitol-6’-triphosphate-tetrabutylammonium salt
(28)
Protected h-isoCMe 27 (20 mg, 0.057 mmol) was dried overnight
and dissolved in a mixture of anhydrous pyridine (0.6 mL) and di-
oxane (1 mL). Salicyl phosphorochloridite (14.0 mg, 0.068 mmol)
was added as a solution in dioxane (0.3 mL) and the reaction mix-
ture was stirred at 25 8C for 1 min under nitrogen. The solution
became dark brown. A solution of tributylammonium pyrophos-
phate (41.3 mg, 0.091 mmol) in DMF (0.5 mL) and tributylamine
(0.064 mL, 0.267 mmol) were added to the reaction mixture and
stirred for 20 min. A solution of iodine (0.68 mL, 0.068 mmol) in
pyridine/H2O (98/2) was added and the resulting solution was
stirred for 20 min, then quenched with 5% Na2SO3 until the red
colour disappeared. The solvent was evaporated and the residue
was treated with 25% ammonia (4 mL). The solution was evaporat-
ed to dryness, the residue was re-dissolved in water (5 mL) and pu-
rified as described for h-isoGTP above to give h-isoCMeTP. 31P NMR
(121 MHz, D2O): d=¢10.85 (2P, br s), ¢23.24 ppm (1P, t) ; HRMS
(ESI): calcd for C11H20N3O13P3 : 494.0136 [M¢H]¢ ; found: 494.0141.
Oligonucleotide synthesis
Oligonucleotide assemblywas performed with an Expedite DNA
synthesiser (Applied Biosystems) by using the phosphoramidite ap-
proach. The oligomers were deprotected and cleaved from the
solid support by treatment with aqueous ammonia (30%) for 2 h.
After gel filtration on a NAP-25 column (Sephadex G25-DNA grade;
Pharmacia) with water as the eluent, the crude mixture was ana-
lysed by using a Mono-Q HR 5/5 anion exchange column, after
which purification was achieved by using a Mono-Q HR 10/100 GL
column (Pharmacia) with the following gradient system: A=10 mm
NaClO4 in 15% CH3CN, pH 7.4, B=600 mm NaClO4 in 15% CH3CN,
pH 7.4. The low-pressure liquid chromatography system consisted
of a Merck–Hitachi L-6200 A intelligent pump, a Mono-Q HR 10/
100 GL column (Pharmacia), an Uvicord SII 2138 UV detector (Phar-
macia-LKB) and a recorder. The product-containing fraction was de-
salted on a NAP-25 column and lyophilised (Table 8).
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UV melting experiments
Oligomers were dissolved in a buffer solution containing NaCl
(0.1m), potassium phosphate (0.02m, pH 7.5) and EDTA (0.1 mm).
The concentration was determined by measuring the absorbance
in Milli-Q water at 260 nm at 80 8C, and by assuming that hexitol
nucleosides have the same extinction coefficients per base moiety
in the denatured state as the natural nucleosides (A*, e=15000;
T*, e=8500). The concentration for each strand was 4 mm in all ex-
periments. Melting curves were determined with a Varian Cary 100
BIO spectrophotometer. Cuvettes were maintained at constant
temperature by water circulation through the cuvette holder. The
temperature of the solution was measured with a thermistor that
was directly immersed in the cuvette. Temperature control and
data acquisition were carried out automatically with an IBM-com-
patible computer by using Cary WinUV thermal application soft-
ware. A quick heating and cooling cycle was carried out to allow
proper annealing of both strands. The samples were then heated
from 10 to 80 8C at a rate of 0.2 8Cmin¢1, and were cooled again at
the same speed. Melting temperatures were determined by plot-
ting the first derivative of the absorbance as a function of temper-
ature; data plotted were the average of two runs. Up and down
curves in general showed identical Tm values.
Incorporation experiments
All the natural triphosphates were purchased from GE Healthcare
(HPLC purification) or TriLink Biotechnologies (HPLC purification).
The natural oligonucleotides were purchased from IDT (in lyophi-
lised form) and reconstituted with Milli-Q water to give 100 mm.
Vent (exo-), Taq and KF (exo-) polymerases were purchased from
New England Biolabs, Pfu (exo-) from Agilent Technologies, Tfi
(exo-) from Life technologies, T7 sequenase from Affymetrix,
T4(exo-) from Lucigen and Pol III a-subunit was expressed and pu-
rified as described.[32]
First, the primer (P1) was 5’- labeled with [33P]ATP (3000 Cimmol¢1,
10 mCimL¢1) (Perkin–Elmer) using T4 polynucleotide kinase (10 U/
mL) (New England Biolabs), following the procedures suggested by
the manufacturer. The unincorporated radionucleotides were re-
moved using Illustra Microspin G-25 columns (GE Healthcare). The
end-labelled primer was annealed to each template (primer: tem-
plate molar ratio of 1:2) by heating the mixture at 70 8C for 4 min,
followed by slowing cooling to room temperature over a period of
2 h. A series of 10 mL reactions were performed for all of the DNA
polymerases. Incorporation experiments were duplicated and tripli-
cates were obtained for the selectivity tests to ensure the accuracy
of the results. Each batch reaction contained 125 nm of the pri-
mer:template, 1Õreaction buffer (as provided by the supplier),
0.08 UmL¢1 of TIPP, 0.08 UmL¢1 of the DNA polymerases except
1.6 UmL¢1 for Pol III a-subunit and varying nucleoside triphosphate
concentrations (d-NTP or h-NTP). The reaction mixtures were incu-
bated at 75 8C for Vent (exo-), Pfu (exo-), Taq and Tfi (exo-), at 37 8C
for KF (exo-), T4 (exo-) and T7 sequenase version and at 30 8C for
Pol III a-subunit. 2.0 mL aliquots were removed and quenched (by
addition of 5 mL loading dye) at the desired time points. Loading
dye consists of: 90% formamide, 0.05% xylene cyanol, 0.05% bro-
mophenol blue and 50 mm EDTA. The samples were analysed by
gel electrophoresis for 2–3 h at 2000 V on a 30 cmÕ40 cmÕ
0.4 mm 20% denaturing gel in the presence of 100 mm Tris-Borate
and 2.5 mm EDTA buffer (pH 8.3). The bands corresponding to the
enzymatic reaction products were visualised using the Optiquant
Image Analysis software (Perkin–Elmer).
In vivo assay of XNA-oligonucleotides
Oligomers were dissolved in Milli-Q water to 100 mm and diluted
ten-fold before assay. Oligomers were tested inside a gapped het-
eroduplex vector generated through the enzymatic digestion and
PCR assisted denaturation and hybridisation of the ampicillin resist-
ance gene containing pAK1 and pAK2 plasmids.[24] The form of the
plasmids are described elsewhere in detail.[23,24] Here, a mix of equi-
molar (25 ng each) purified NheI and NsiI cut pAK1 and purified
two-fold EcoRI cut and dephosphorylated pAK2 were diluted in
10 mm Tris-HCl (pH 7.5) with 100 mm NaCL. The mixture was dena-
tured at 95 8C for 5 min before cooling to ambient temperature
over 2 h, before subsequent dialysis with water through 0.05 mm
nitrocellulose filters (Millipore) for 30 min. Each oligomer for testing
(0.02 pmol), as well as a positive (CTAGCGCCGTGCCATGCA) and
negative (CTAGCGCCGCATGCA) oligomer control, was added to
the dialysed heteroduplex mixture in 1Õ DNA ligase T4 reaction
buffer (NEB) to 20 mL each. The mixture was denatured at 85 8C as
before. Ligation was performed by adding 1 mm ATP and 5 U T4
DNA Ligase (NEB) to the samples before overnight incubation at
16 8C. Ligated mixtures were dialysed as before, and transformed
by electroporation into a competent strain of E. coli K12 (DthyA :aa-
dA). Incubation of the electroporated mixture was performed at
37 8C for 1 hour, before plating 100 mL of sub-dilutions of the mix-
ture onto Muller-Hinton (MH) media containing 100 mgmL¢1 ampi-
cillin (10¢1 and 10¢2 dilutions) and onto the same media supple-
mented with 0.3 mm thymidine (10¢3 and 10¢4 dilutions).
Data analysis and sequencing
The total number of thymidine–prototrophic and of ampicillin re-
sistant colonies was calculated from the plate counts, and the ratio
(former/latter) was recorded. Positive thymidine-prototrophic colo-
nies were picked and restreaked twice overnight to MH ampicillin
(100 mgmL¢1), before overnight growth in 2 mL liquid cultures of
the same medium. Plasmids were prepared by Miniprep (Qiagen)
and the plasmids sequenced using an inter-thyA oligo (AA-
CAGTGGCGCGCCTGG).
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